礼来公司表示，其口服减肥药Foundayo在2型糖尿病成人患者中，比诺和诺德更高剂量的Ozempic口服药能带来更大的减重效果和更好的血糖控制，并引用了现有研究的数据。
Eli Lilly said its oral obesity drug, Foundayo, offers greater weight loss and better blood sugar control than a higher dose of Novo Nordisk's Ozempic pill in adults with type 2 diabetes, citing data from existing studies.